相关实验视频

Updated: Jun 28, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

克服当前药物反应措施的局限性可能使人工智能驱动的精确瘤学成为可能

Katja Ovchinnikova¹, Jannis Born², Panagiotis Chouvardas^1,3

¹Urology Research Laboratory, Department for BioMedical Research, University of Bern, Bern, Switzerland.

NPJ precision oncology

|April 24, 2024

概括

标准的药物敏感度测量在精确瘤学中失败,因为它忽视了癌症亚型的差异. 使用z得分的响应可以改善机器学习 (ML) 模型的个性化癌症药物预测.

科学领域:

在瘤学瘤学.
生物信息学是一种生物信息学.
计算生物学计算生物学

背景情况:

机器学习 (ML) 模型越来越多地用于精确瘤学的药物敏感性预测.
目前的预测模型面临局限性,因为标准的药物敏感度测量侧重于绝对效应,而不是癌症亚型之间的相对差异.

研究的目的:

识别和解决标准药物敏感度测量中的基本局限性,这阻碍了个性化的预测模型.
提出一种改进的药物反应测量方法,以提高精密瘤学ML模型的性能.

主要方法:

分析标准药物敏感度指标以确定局限性.
应用z分数药物反应措施作为一种替代方法.
开发和评估ML模型,使用标准和z-scored措施.

主要成果:

标准的药物敏感度测量不能捕捉癌症亚型之间的关键相对差异.
Z-评分药物反应措施有效地减轻了标准措施的局限性.
使用z得分响应的ML模型为个性化瘤学提供了更有意义和更准确的预测.

结论:

Z-评分药物反应措施是开发复杂的ML驱动精密瘤学模型的关键改进.
这种方法克服了绝对效果测量的局限性,使得更好的个性化药物敏感性预测成为可能.
这些发现为在癌症治疗中更先进,更有效的ML应用铺平了道路.

更多相关视频

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...